% | $
Quotes you view appear here for quick access.

Orexigen Therapeutics, Inc. (OREX) Message Board

  • ccharles792 ccharles792 Sep 9, 2012 8:18 PM Flag

    "OREX to be Favorite of Obesity Drugs" link

    An analyst at Credit Suisse says investors are too enthusiastic in their belief the anti-obesity market will enjoy multiple winners, but if there is going to be one, Orexigen Therapeutics (Nasdaq: OREX ) has to be considered. When and if its fat-fighting drug Contrave is approved and brought to market sometime in 2014, it should grab a good portion of what's estimated to grow to a $3.5 billion industry by 2020.

6.545-0.175(-2.60%)11:27 AMEDT